Clinical Trials on Glabellar Crease in United Kingdom
Total 7463 results
-
Gary SchwartzUniversity of Colorado, Denver; North Shore University HospitalTerminatedMetastatic Breast CancerUnited States
-
AstraZenecaNot yet recruiting
-
Medstar Health Research InstituteGenentech, Inc.CompletedLeft Ventricular Function Systolic Dysfunction | HER2 Positive Breast CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Genentech... and other collaboratorsCompletedBreast Cancer | Metastatic Breast Cancer | Progressive Breast CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerSweden, Canada, South Africa, Spain, United Kingdom, Germany, Taiwan, Switzerland, New Zealand, Italy, Bosnia and Herzegovina, Serbia, Portugal, Greece, Romania, Brazil, Korea, Republic of, Mexico, Croatia, Bahamas
-
Wake Forest UniversityTerminatedNewly Diagnosed Breast CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); MedImmune LLC; Avon Breast Cancer FoundationCompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu NegativeUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Cancer and Leukemia Group BCompleted
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruiting
-
Mayo ClinicNational Cancer Institute (NCI)CompletedBreast CarcinomaUnited States
-
Hoffman OncologyDSCS CROActive, not recruiting
-
University of Colorado, DenverUnited States Department of DefenseCompleted
-
SOLTI Breast Cancer Research GroupDana-Farber Cancer Institute; Novartis Pharmaceuticals; Stand Up To CancerCompletedBreast CancerUnited States, Spain
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)Completed
-
Emory UniversityGenentech, Inc.; Novartis PharmaceuticalsCompletedBreast CancerUnited States
-
Avelas Biosciences, Inc.CompletedBreast CancerUnited States
-
University of ChicagoRoche Pharma AG; Breast Cancer Research FoundationTerminatedBreast CancerUnited States, Nigeria
-
Gilead SciencesCompletedMetastatic Breast CancerUnited States, Spain, United Kingdom, Italy, Canada, France, Germany, Belgium, Netherlands
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruitingMetastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Invasive Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterCompletedMetastatic Breast CancerUnited States
-
Mayo ClinicRecruitingBreast CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Fertility PreservationUnited States
-
Case Comprehensive Cancer CenterCompleted
-
University of Texas Southwestern Medical CenterTexas Tech University Health Sciences CenterWithdrawnImpact of Body Weight on Pharmacokinetic Analysis of Doxorubicin + Cyclophosphamide in Breast CancerBreast CancerUnited States
-
Ohio State University Comprehensive Cancer CenterGenentech, Inc.; National Comprehensive Cancer NetworkCompletedBreast CancerUnited States
-
Masonic Cancer Center, University of MinnesotaTerminatedBreast CancerUnited States
-
National Cancer Institute (NCI)Cancer and Leukemia Group BCompletedBreast Cancer | High Risk | Cyclophosphamide | Positive Nodes | DoxorubicinUnited States
-
Paula Silverman, MDNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedBreast Cancer | Hot FlashesUnited States
-
Indiana University School of MedicineCompleted
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
National Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedBreast CancerUnited States
-
University of VirginiaNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedBreast CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Estrogen Receptor Positive | Progesterone Receptor Positive | Postmenopausal | KIT Positive | PDGFR PositiveUnited States
-
Vanderbilt UniversityCompleted
-
M.D. Anderson Cancer CenterCompleted
-
Wake Forest University Health SciencesAtrium Health Levine Cancer InstituteRecruitingBreast Cancer | Cancer DistressUnited States
-
Milton S. Hershey Medical CenterNRG OncologyCompletedPhysical Activity | Breast NeoplasmUnited States
-
Spectrum Pharmaceuticals, IncTerminatedBreast CancerUnited States
-
University of ArkansasAngiodynamics, Inc.CompletedCancer of the BreastUnited States
-
University of California, San FranciscoCompleted
-
St. Louis UniversityUnknownBreast CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingInvasive Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor PositiveUnited States
-
University of Colorado, DenverInternational Society for the Study of Women's Sexual HealthCompletedSexual Dysfunction | Breast Cancer FemaleUnited States